KRAS MUTATION ANALYSIS BY PCR
therascreen® KRAS RGQ PCR, KRAS, therascreen
Seven somatic mutations in the human KRAS oncogene
therascreen® KRAS RGQ PCR is a companion diagnostic for ERBITUX®.
Specimen Collection Requirements
Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue. Protect from excessive heat. Transport tissue block or 5 unstained 5-10micron slides. (Min: 3 slides)
Specimens fixed/processed in alternative fixatives (alcohol, Prefer®), frozen or decalcified specimens
Ambient: Indefinitely; Refrigerated: Indefinitely; Frozen: Unacceptable
This real time PCR assay uses the FDA-approved, Qiagen therascreen in vitro diagnostics (IVD) kit to detect the major KRAS mutations involving codon 12 and 13.
Thursday, January 5, 2017 03:41:46 AM
Client Services: 503-413-1234